US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tempus AI

51.67

-2.6200-4.83%

Pre-market: 53.772.10+4.06%09:28 EDT

Volume:8.11M

Turnover:416.61M

Market Cap:8.94B

PE:-8.30

High:52.25

Open:51.20

Low:50.05

Close:54.29

Loading ...

Overview Company News Filings

Tempus Time Network Expands Support of Phase I Clinical Trials to Accelerate Activation and Enrollment

THOMSON REUTERS

Stock Track | Tempus AI (TEM) Soars 5.12% as Liquid Biopsy Assay Receives Validation in Prestigious Journal

Stock Track | Tempus AI Soars 5.06% Pre-market on Publication of Liquid Biopsy Assay Validation Study

Stock Track | Tempus AI (TEM) Surges 5.06% Pre-market Following Publication of Validation Study for Liquid Biopsy Assay

Tempus Publishes Study Validating the Benefits of xF+, its Comprehensive Liquid Biopsy Assay for Therapy Selection

tempus AI Inc Class A call volume above normal and directionally bullish

Analysts Split on High-Stakes ‘Call Option’ for Tempus AI Stock (TEM)

Stock Track | Tempus AI Soars 5.09% on Launch of AI-Powered Target Discovery Platform

Stock Track | Tempus AI Soars 5.09% as Company Unveils AI-Powered Drug Discovery Platform

Tempus Introduces Loop, an AI-Powered Target Discovery and Validation Platform

Why Tempus AI Inc. (TEM) Soared Last Week

AI Shares Jump Premarket; BigBear.ai up 5%; AppLovin up 4%; Trade Desk up 3%; Palantir, Tempus AI, SoundHound AI up 2%

Tiger Newspress

Tempus AI Stock Sees 21% Gain in 3 Days: Is it a Buy After AZN Deal?

Stock Track | Tempus AI Soars 5.03% as AI Sector Rallies and Q1 Earnings Announcement Looms

AI Software Shares Jump. ServiceNow up 14%; SoundHound AI, Atlassian up 6%; Salesforce, Palantir, Snowflake up 4%

Tiger Newspress

Press Release: Tempus to Report First Quarter 2025 Financial Results on May 6

Tempus AI Price Target Maintained With a $70.00/Share by Needham

Tempus AI Stock (TEM) Surges over 14% in a Day – What’s Next for Investors?

24H｜Pony AI Soared 13%; ServiceNow Up 10%; Texas Instruments Up 5%; Tempus AI Up 3%; IBM Down 7%

Tiger Newspress

Tempus AI, Inc. (TEM): A Bull Case Theory

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/TEM/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TEM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TEM\",,,,,undefined,":{"symbol":"TEM","market":"US","secType":"STK","nameCN":"Tempus AI","latestPrice":51.67,"timestamp":1746043200000,"preClose":54.29,"halted":0,"volume":8113186,"hourTrading":{"tag":"盘前","latestPrice":53.77,"preClose":51.67,"latestTime":"09:28 EDT","volume":150028,"amount":8004599.012952,"timestamp":1746106126970},"delay":0,"floatShares":98993571,"shares":173032863,"eps":-6.227252,"marketStatus":"Pre-Mkt","change":-2.62,"latestTime":"05-01 09:28:51 EDT","open":51.195,"high":52.25,"low":50.05,"amount":416613204.49329597,"amplitude":0.040523,"askPrice":54,"askSize":15,"bidPrice":53.5,"bidSize":250,"shortable":3,"etf":0,"ttmEps":-6.227252,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1746106200000},"marketStatusCode":1,"adr":0,"listingDate":1718337600000,"exchange":"NASDAQ","adjPreClose":51.67,"preHourTrading":{"tag":"盘前","latestPrice":53.77,"preClose":51.67,"latestTime":"09:28 EDT","volume":150028,"amount":8004599.012952,"timestamp":1746106126970},"postHourTrading":{"tag":"盘后","latestPrice":53.17,"preClose":51.67,"latestTime":"19:59 EDT","volume":267897,"amount":14100297.5092,"timestamp":1746057592197},"volumeRatio":0.6872746470286815,"impliedVol":1.0589,"impliedVolPercentile":0.5581},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TEM\",,,,,undefined,":{"symbol":"TEM","floatShares":98993571,"roa":"-57.96%","roe":"--","lyrEps":-6.227252,"volumeRatio":0.6872746470286815,"shares":173032863,"dividePrice":0,"high":52.25,"amplitude":0.040523,"preClose":54.29,"low":50.05,"week52Low":22.89,"pbRate":"158.69","psRate":"12.89","week52High":91.45,"institutionHeld":0,"latestPrice":51.67,"committee":0.886792,"eps":-6.227252,"divideRate":0,"volume":8113186,"delay":0,"ttmEps":-6.227252,"open":51.195,"prevYearClose":33.76,"fiveDayClose":49.55,"twentyDayClose":47.22,"sixtyDayClose":61.54,"earningDate":1746460800000,"earningTime":"盘后"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TEM\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2532963074","title":"Tempus Time Network Expands Support of Phase I Clinical Trials to Accelerate Activation and Enrollment","url":"https://stock-news.laohu8.com/highlight/detail?id=2532963074","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532963074?lang=en_us&edition=fundamental","pubTime":"2025-05-01 20:30","pubTimestamp":1746102603,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250501:nTUAPGFHS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TEM","BK4613","BK4611","BK4121","LU1861559042.SGD","LU1861558580.USD"],"gpt_icon":0},{"id":"1198985796","title":"Stock Track | Tempus AI (TEM) Soars 5.12% as Liquid Biopsy Assay Receives Validation in Prestigious Journal","url":"https://stock-news.laohu8.com/highlight/detail?id=1198985796","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198985796?lang=en_us&edition=fundamental","pubTime":"2025-04-29 21:32","pubTimestamp":1745933571,"startTime":"0","endTime":"0","summary":"Shares of Tempus AI  surged 5.12% in pre-market trading on Tuesday, as the precision medicine technology company announced a significant milestone for its comprehensive liquid biopsy assay, xF+. The rally was fueled by the publication of a validation study in the prestigious Journal of Molecular Diagnostics, which adds substantial credibility to Tempus AI's product offering.Dr. Ezra Cohen, Chief Medical Officer of Oncology at Tempus, commented on the publication, stating, \"When we first introduc","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["TEM"],"gpt_icon":0},{"id":"1151456595","title":"Stock Track | Tempus AI Soars 5.06% Pre-market on Publication of Liquid Biopsy Assay Validation Study","url":"https://stock-news.laohu8.com/highlight/detail?id=1151456595","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151456595?lang=en_us&edition=fundamental","pubTime":"2025-04-29 20:48","pubTimestamp":1745930909,"startTime":"0","endTime":"0","summary":"Tempus AI  saw its stock surge 5.06% in pre-market trading on Tuesday, following the announcement of a significant publication validating the company's comprehensive liquid biopsy assay. The biotechnology firm, which specializes in AI-driven precision medicine, released news of the study just before the market opened, triggering investor enthusiasm.Tempus AI, known for its large multimodal data library and AI-enabled precision medicine solutions, may see this validation as a significant boost to","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["TEM"],"gpt_icon":0},{"id":"1121878081","title":"Stock Track | Tempus AI (TEM) Surges 5.06% Pre-market Following Publication of Validation Study for Liquid Biopsy Assay","url":"https://stock-news.laohu8.com/highlight/detail?id=1121878081","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121878081?lang=en_us&edition=fundamental","pubTime":"2025-04-29 20:48","pubTimestamp":1745930907,"startTime":"0","endTime":"0","summary":"Shares of Tempus AI  soared 5.06% in pre-market trading on Tuesday, as the precision medicine technology company announced the publication of a validation study for its comprehensive liquid biopsy assay, xF+, in the prestigious Journal of Molecular Diagnostics.The study, titled \"Analytical Validation of NGS-based Comprehensive Liquid Biopsy Assay for Therapy,\" supports the utility of xF+ as a non-invasive technique for detecting actionable variants, identifying clinically relevant biomarkers, an","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Stock Track | Tempus AI (TEM) Surges 5.06% Pre-market Following Publication of Validation Study for Liquid Biopsy Assay","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["TEM"],"gpt_icon":0},{"id":"2531973698","title":"Tempus Publishes Study Validating the Benefits of xF+, its Comprehensive Liquid Biopsy Assay for Therapy Selection","url":"https://stock-news.laohu8.com/highlight/detail?id=2531973698","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531973698?lang=en_us&edition=fundamental","pubTime":"2025-04-29 20:30","pubTimestamp":1745929800,"startTime":"0","endTime":"0","summary":"The validation study recently published in the Journal of Molecular Diagnostics. CHICAGO, April 29, 2025----Tempus AI, Inc. , a technology company leading the adoption of AI to advance precision medicine and patient care, today announced publication of its study, \"Analytical Validation of NGS-based Comprehensive Liquid Biopsy Assay for Therapy\" in the Journal of Molecular Diagnostics. Data from this study supports the utility of xF+ as a non-invasive technique to detect actionable variants including resistance mutations, identify clinically relevant biomarkers, and monitor disease progression.The xF+ assay integrates with the Tempus multimodal database, supporting therapeutic recommendations and clinical research. Originally introduced in 2022, the xF+ panel covers 523 genes spanning ~1.8 Mb of the human genome. The validation study shows that the xF+ assay shows concordance with the Tempus xF and xT assays for MSI status and gene coverage. The assay exhibits accuracy, sensitivity, spe","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tempus-publishes-study-validating-benefits-123000329.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4611","LU1861558580.USD","BK4121","LU1861559042.SGD","TEM","BK4613"],"gpt_icon":1},{"id":"2531317222","title":"tempus AI Inc Class A call volume above normal and directionally bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=2531317222","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531317222?lang=en_us&edition=fundamental","pubTime":"2025-04-28 23:45","pubTimestamp":1745855106,"startTime":"0","endTime":"0","summary":"Bullish option flow detected in tempus AI (TEM) Inc Class A with 23,202 calls trading, 3x expected, and implied vol increasing almost 2 points to 1...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-inc-class-a-call-volume-above-normal-and-directionally-bullish-7?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-inc-class-a-call-volume-above-normal-and-directionally-bullish-7?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4613","BK4611","LU1861558580.USD","TEM","BK4121","LU1861559042.SGD"],"gpt_icon":0},{"id":"2530239171","title":"Analysts Split on High-Stakes ‘Call Option’ for Tempus AI Stock (TEM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2530239171","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530239171?lang=en_us&edition=fundamental","pubTime":"2025-04-28 23:25","pubTimestamp":1745853957,"startTime":"0","endTime":"0","summary":"Tempus AI ($TEM) stock rallied after revealing a multi-year, strategic collaboration with AstraZeneca ($AZN) and Pathos AI. The deal represents an ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/analysts-split-on-high-stakes-call-option-for-tempus-ai-stock-tem?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/analysts-split-on-high-stakes-call-option-for-tempus-ai-stock-tem?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4611","LU1861558580.USD","BK4121","LU1861559042.SGD","TEM","BK4613"],"gpt_icon":0},{"id":"1141662586","title":"Stock Track | Tempus AI Soars 5.09% on Launch of AI-Powered Target Discovery Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=1141662586","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141662586?lang=en_us&edition=fundamental","pubTime":"2025-04-28 21:44","pubTimestamp":1745847899,"startTime":"0","endTime":"0","summary":"Tempus AI  stock is soaring 5.09% in pre-market trading on Monday following the announcement of its new AI-powered target discovery and validation platform, Tempus Loop. The platform aims to revolutionize oncology research and drug development by integrating real-world patient data with advanced biological modeling and CRISPR screens.Tempus Loop addresses a significant challenge in the pharmaceutical industry: the high failure rate of preclinical assets in becoming real-world medicines. By lever","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["TEM"],"gpt_icon":0},{"id":"1152274748","title":"Stock Track | Tempus AI Soars 5.09% as Company Unveils AI-Powered Drug Discovery Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=1152274748","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152274748?lang=en_us&edition=fundamental","pubTime":"2025-04-28 21:44","pubTimestamp":1745847886,"startTime":"0","endTime":"0","summary":"Tempus AI  saw its stock soaring 5.09% in pre-market trading on Monday following the announcement of its new AI-powered target discovery and validation platform, Tempus Loop. This innovative platform aims to accelerate novel target identification in oncology, potentially revolutionizing the drug discovery process.The newly introduced Tempus Loop integrates real-world patient data  with human-derived biological models and CRISPR-screens, leveraging AI to rapidly uncover insights for pre-clinical ","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Stock Track | Tempus AI Soars 5.09% as Company Unveils AI-Powered Drug Discovery Platform","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["TEM"],"gpt_icon":0},{"id":"2530402727","title":"Tempus Introduces Loop, an AI-Powered Target Discovery and Validation Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2530402727","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530402727?lang=en_us&edition=fundamental","pubTime":"2025-04-28 20:30","pubTimestamp":1745843400,"startTime":"0","endTime":"0","summary":"The new, proprietary target discovery platform integrates RWD, human biological modeling, and CRISPR screens to accelerate novel target identification. One of the biggest industry challenges has been translating promising preclinical experiments into treatments that can benefit patients. Conventional approaches in target discovery and validation rely on cell lines or animal models, which may not be reliable representations of human tumors. Loop’s approach is uniquely powerful because it leverages Tempus’ rich RWD to identify patient subpopulations with similar clinical, pathologic, and molecular patterns, followed by use of systems biological approaches to help reveal novel target genes and multimodal signatures. These signatures allow Tempus to seamlessly map patient subcohorts to relevant patient-derived organoids , which the company has been expanding for years. By ensuring continuity between RWD and PDOs, Tempus can validate targets using high-throughput functional screens in model","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tempus-introduces-loop-ai-powered-123000978.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1861559042.SGD","LU1861558580.USD","TEM","BK4611","BK4613","BK4121"],"gpt_icon":1},{"id":"2530175339","title":"Why Tempus AI Inc. (TEM) Soared Last Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2530175339","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530175339?lang=en_us&edition=fundamental","pubTime":"2025-04-27 02:04","pubTimestamp":1745690649,"startTime":"0","endTime":"0","summary":"We recently published a list of Why These 10 Firms Recorded Double-Digit Gains Last Week. In this article, we are going to take a look at where Tempus AI Inc.  stands against other firms that recorded double-digit gains last week.Ten companies finished the past trading week on a high note, outperforming the three major indices with double-digit gains amid a flurry of catalysts, including upcoming earnings releases, that sparked buying appetite.Week-on-week, the Nasdaq rallied by 6.7 percent, the S&P 500 clocked in a 4.59-percent gain, while the Dow Jones was up by 2.48 percent.In other news, Tempus AI Inc.  clinched a new $200-million deal with AstraZeneca and Pathos AI for the development of a multimodal foundation model in oncology. The total amount includes data licensing and model development fees.Overall, TEM ranks 4th on our list of firms that recorded double-digit gains last week. While we acknowledge the potential of TEM as an investment, our conviction lies in the belief that ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-tempus-ai-inc-tem-180409062.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SQQQ","TQQQ","TSYW.SI","USAW.SI","QID",".IXIC","BK4121","NVIW.SI","NQmain","LU1861558580.USD","QLD","TEM","USJW.SI","LU1861559042.SGD","BK4613","PSQ","BK4611","MNQmain"],"gpt_icon":1},{"id":"1137528710","title":"AI Shares Jump Premarket; BigBear.ai up 5%; AppLovin up 4%; Trade Desk up 3%; Palantir, Tempus AI, SoundHound AI up 2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1137528710","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137528710?lang=en_us&edition=fundamental","pubTime":"2025-04-25 16:08","pubTimestamp":1745568538,"startTime":"0","endTime":"0","summary":"AI shares jumped in premarket trading on Friday. BigBear.ai rose 5%; AppLovin up 4%; Trade Desk up 3%; Palantir, Tempus AI, SoundHound AI up 2%; Cloudflare up 1%.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVDA","TTD","BK4566","IE00BGHQF748.EUR","UPST","BK4116","BK4551","BK4112","BK4528","TEM","LU1861558580.USD","LU2265009873.SGD","LU2357305700.SGD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","LU0390134368.USD","BIDU","LU1861559042.SGD","BBAI","SOUN","LU1548497426.USD","BK4524","LU1720051017.SGD","LU0823421333.USD","BK4532","LU0823421416.USD","BK4548","BK4588","LU1720051108.HKD","LU1804176565.USD","LU2210149790.SGD","LU2095319765.USD","APP","PLTR","LU2210150020.SGD","BK4585","IE00B64PRP62.GBP","BK4613","AI"],"gpt_icon":0},{"id":"2530962679","title":"Tempus AI Stock Sees 21% Gain in 3 Days: Is it a Buy After AZN Deal?","url":"https://stock-news.laohu8.com/highlight/detail?id=2530962679","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530962679?lang=en_us&edition=fundamental","pubTime":"2025-04-25 03:00","pubTimestamp":1745521200,"startTime":"0","endTime":"0","summary":"Tempus AI TEM has skyrocketed 21% in the last three days, fueled by news of a $200 million partnership with AstraZeneca AZN and Pathos AI. The multi-year deal focuses on building a multimodal AI-driven foundation model for oncology, using TempusAI’s de-identified oncology data. This partnership is a big win, matching Tempus AI’s fourth-quarter 2024 revenues alone.But with the stock on fire, the big question is, will the rally continue, or is Tempus AI already priced for perfection?TEM-AZN-Pathos AI Deal to Build Foundation for Long-term Stability. This partnership not only highlights the value of TEM’s AI and data assets but also deepens its existing relationship with AstraZeneca. With the deal value alone matching Tempus AI’s fourth-quarter 2024 revenues, it’s a major milestone that could lead to more licensing opportunities and position Tempus as a key player in AI-driven precision medicine.Not only this, the launch of the xT CDx in vitro diagnostic device and the Olivia health conci","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tempus-ai-stock-sees-21-190000403.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TEM","LU2087621335.USD","LU2456880835.USD","IE00BKPKM429.USD","LU0353189680.USD","GB00B4QBRK32.GBP","LU1670627923.USD","LU2491050071.SGD","LU0868494617.USD","LU0345769631.USD","LU2125154778.USD","LU2362541273.HKD","LU2360032135.SGD","LU1032955483.USD","AZN","LU1116320737.USD","BK4077","LU0130517989.USD","LU1043141123.HKD","LU2505996681.GBP","LU1951198990.SGD","LU2592432038.USD","LU0708994859.HKD","LU0203347892.USD","LU2242649171.HKD","LU1935043536.SGD","LU1778281490.HKD","LU1699723380.USD","LU2168564495.EUR","LU0354030438.USD","LU2236285917.USD","LU0130518102.USD","LU1066051811.HKD","SGXZ99366536.SGD","LU2168564065.EUR","LU0820562030.AUD","BK4598","LU0823434583.USD","LU2471134796.USD","IE00BMPRXN33.USD","LU2097344357.USD","SG9999015945.SGD","IE00BMPRXR70.SGD","IRTC","LU2087625088.SGD","LU0690374615.EUR","SOPH","LU0942090050.USD","LU1951200564.SGD"],"gpt_icon":1},{"id":"1136718619","title":"Stock Track | Tempus AI Soars 5.03% as AI Sector Rallies and Q1 Earnings Announcement Looms","url":"https://stock-news.laohu8.com/highlight/detail?id=1136718619","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136718619?lang=en_us&edition=fundamental","pubTime":"2025-04-25 01:00","pubTimestamp":1745514025,"startTime":"0","endTime":"0","summary":"Tempus AI , a leader in artificial intelligence and precision medicine, saw its stock soar 5.03% in intraday trading on Thursday. This surge comes on the heels of a remarkable 14.62% gain the previous day, indicating strong momentum for the AI-focused company.The stock's upward trajectory appears to be driven by multiple factors. Firstly, Tempus AI announced it will report its first quarter 2025 financial results on May 6, which has likely piqued investor interest. The upcoming earnings call, fe","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["TEM"],"gpt_icon":0},{"id":"1123127017","title":"AI Software Shares Jump. ServiceNow up 14%; SoundHound AI, Atlassian up 6%; Salesforce, Palantir, Snowflake up 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1123127017","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123127017?lang=en_us&edition=fundamental","pubTime":"2025-04-24 21:47","pubTimestamp":1745502455,"startTime":"0","endTime":"0","summary":"AI application software shares jumped on Thursday. ServiceNow up 14%; SoundHound AI, Atlassian up 6%; Salesforce, Palantir, Snowflake up 4%; Tempus AI, AppLovin up 3%.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","IE00BGHQF748.EUR","BK4528","LU0390134368.USD","BK4532","LU1861558580.USD","IE00B3QW5Z07.USD","LU1861559042.SGD","TEM","LU1548497426.USD","BK4112","DUOL","LU2210150020.SGD","BK4551","LU0823421416.USD","LU2265009873.SGD","BK4524","LU1720051108.HKD","LU2210149790.SGD","BK4548","APP","BK4116","IE00BKPKM429.USD","TEAM","SHOP","BK4588","BK4566","LU1804176565.USD","BK4585","LU1720051017.SGD","LU2357305700.SGD","LU2095319765.USD","LU0823421333.USD","BK4613"],"gpt_icon":0},{"id":"2529898436","title":"Press Release: Tempus to Report First Quarter 2025 Financial Results on May 6","url":"https://stock-news.laohu8.com/highlight/detail?id=2529898436","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529898436?lang=en_us&edition=fundamental","pubTime":"2025-04-24 20:33","pubTimestamp":1745497980,"startTime":"0","endTime":"0","summary":"Tempus AI, Inc. , a leader in artificial intelligence and precision medicine, today announced they will report financial results for the first quarter of 2025 on Tuesday, May 6, 2025. The company will hold the earnings conference call at 4:30 p.m. ET. The company's quarterly earnings will be released the same day.The call will feature Tempus Founder and CEO, Eric Lefkofsky, and Chief Financial Officer, Jim Rogers. The live audio webcast will be accessible through the events page of Tempus' Investor Relations website. Alternatively, the call can be accessed via the following:. Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world's largest libraries of multimodal data, and an operating system to make that data accessible and useful, Tempus provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, developm","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4611","BK4613","LU1861558580.USD","TEM","LU1861559042.SGD"],"gpt_icon":1},{"id":"2529360677","title":"Tempus AI Price Target Maintained With a $70.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2529360677","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529360677?lang=en_us&edition=fundamental","pubTime":"2025-04-24 18:25","pubTimestamp":1745490300,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TEM/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 24, 2025 06:25 ET (10:25 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEM"],"gpt_icon":0},{"id":"2529061605","title":"Tempus AI Stock (TEM) Surges over 14% in a Day – What’s Next for Investors?","url":"https://stock-news.laohu8.com/highlight/detail?id=2529061605","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529061605?lang=en_us&edition=fundamental","pubTime":"2025-04-24 18:14","pubTimestamp":1745489672,"startTime":"0","endTime":"0","summary":"Tempus AI ($TEM) has seen a significant surge on Wednesday, with its stock climbing 14.62% in just one day. The significant boost in TEM stock foll...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/tempus-ai-stock-tem-surges-over-14-in-a-day-whats-next-for-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/tempus-ai-stock-tem-surges-over-14-in-a-day-whats-next-for-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1861559042.SGD","TEM","LU1861558580.USD","ISBC","BK4121","BK4613","BK4611","BK4211"],"gpt_icon":0},{"id":"1114385879","title":"24H｜Pony AI Soared 13%; ServiceNow Up 10%; Texas Instruments Up 5%; Tempus AI Up 3%; IBM Down 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1114385879","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114385879?lang=en_us&edition=fundamental","pubTime":"2025-04-24 08:47","pubTimestamp":1745455624,"startTime":"0","endTime":"0","summary":"Shares of Pony AI were kept jumping 13% in overnight trading after surging 30% on Wednesday.Pony AI (PONY) said Wednesday that it has unveiled its seventh-generation autonomous driving system, which i","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PONY","IBM","NOW","TXN","TEM"],"gpt_icon":1},{"id":"2529699661","title":"Tempus AI, Inc. (TEM): A Bull Case Theory","url":"https://stock-news.laohu8.com/highlight/detail?id=2529699661","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529699661?lang=en_us&edition=fundamental","pubTime":"2025-04-24 07:59","pubTimestamp":1745452746,"startTime":"0","endTime":"0","summary":"We came across abullish thesison Tempus AI, Inc.  on Substack by Oliver | MMMT Wealth. In this article, we will summarize the bulls’ thesis on TEM. Tempus AI, Inc. 's share was trading at $43.23 as of April 22nd.Tempus AI, Inc.  is not on our list of the30 Most Popular Stocks Among Hedge Funds. As per our database, 17 hedge fund portfolios held TEM at the end of the fourth quarter which was 7 in the previous quarter. While we acknowledge the risk and potential of TEM as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than TEM but that trades at less than 5 times its earnings, check out our report about thecheapest AI stock.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tempus-ai-inc-tem-bull-235906629.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1861558580.USD","LU1861559042.SGD","BK4611","BK4613","BK4121","TEM"],"gpt_icon":1}],"pageSize":20,"totalPage":20,"pageCount":1,"totalSize":400,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TEM\",params:#limit:5,,,undefined,":[{"date":"2025-05-06","symbol":"TEM","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":-0.47,"defaultRemindTime":1746561600000,"name":null,"time":"Post Market","dateTimestamp":1746504000000,"actualEps":null},{"market":"US","date":"2025-02-24","symbol":"TEM","fiscalQuarterEnding":"2024/12","expectedEps":-0.31,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740373200000,"reportTimeType":"post","actualEps":-0.33},{"market":"US","date":"2025-01-13","symbol":"TEM","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1736744400000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-11-04","symbol":"TEM","fiscalQuarterEnding":"2024/09","expectedEps":-0.4,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730696400000,"reportTimeType":"post","actualEps":-0.38},{"market":"US","date":"2024-08-06","symbol":"TEM","fiscalQuarterEnding":"2024/06","expectedEps":-4.41,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1722916800000,"reportTimeType":"post","actualEps":-6.77}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TEM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TEM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1667,"buy":0.3333,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3333,"analysts":12,"updateTime":1745294400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TEM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TEM","date":"2025-04-30","current":-13.309485,"percent":0.24,"low":-29.603208,"twenty":-13.904149,"median":-11.333112,"eighty":-9.729693,"high":-6.742425,"avg":-12.622378,"sd":4.852985,"marketCap":9393954132},"quantilePoints":[{"date":"2024-06-12","current":-27.212887,"twenty":-27.212887,"median":-27.212887,"eighty":-27.212887,"marketCap":6108857694},{"date":"2024-06-21","current":-20.01629,"twenty":-27.939544,"median":-24.550473,"eighty":-21.368822,"marketCap":4493336948},{"date":"2024-06-28","current":-22.637646,"twenty":-27.212887,"median":-24.73404,"eighty":-22.27051,"marketCap":5081789366},{"date":"2024-07-05","current":-25.251659,"twenty":-26.906925,"median":-25.251659,"eighty":-22.564219,"marketCap":5668593457},{"date":"2024-07-12","current":-27.535249,"twenty":-26.906925,"median":-25.251659,"eighty":-22.667017,"marketCap":6181222875},{"date":"2024-07-15","current":-29.194707,"twenty":-27.212887,"median":-25.292044,"eighty":-22.67436,"marketCap":6553744573},{"date":"2024-08-02","current":-28.842256,"twenty":-27.470777,"median":-25.332429,"eighty":-23.015063,"marketCap":6474624920},{"date":"2024-08-09","current":-8.901726,"twenty":-27.958191,"median":-25.292044,"eighty":-22.343937,"marketCap":6416933507},{"date":"2024-08-16","current":-10.104324,"twenty":-27.470777,"median":-24.480672,"eighty":-9.206046,"marketCap":7283843206},{"date":"2024-08-23","current":-13.814237,"twenty":-27.136397,"median":-22.656003,"eighty":-9.456881,"marketCap":9958186485},{"date":"2024-08-30","current":-12.397063,"twenty":-26.604261,"median":-20.01629,"eighty":-10.261883,"marketCap":8936596611},{"date":"2024-09-06","current":-11.908973,"twenty":-25.699566,"median":-14.657692,"eighty":-10.892118,"marketCap":8584749948},{"date":"2024-09-13","current":-9.729693,"twenty":-25.699566,"median":-13.383947,"eighty":-9.952331,"marketCap":7013785460},{"date":"2024-09-20","current":-10.722999,"twenty":-25.332429,"median":-12.679642,"eighty":-10.104324,"marketCap":7729824284},{"date":"2024-09-27","current":-11.104052,"twenty":-25.251659,"median":-12.364952,"eighty":-10.119309,"marketCap":8004511591},{"date":"2024-10-04","current":-10.481095,"twenty":-25.251659,"median":-11.908973,"eighty":-10.481095,"marketCap":7555444139},{"date":"2024-10-11","current":-9.843153,"twenty":-24.480672,"median":-11.677772,"eighty":-10.292709,"marketCap":7095574377},{"date":"2024-10-18","current":-10.277724,"twenty":-24.377874,"median":-11.503302,"eighty":-10.277724,"marketCap":7408841363},{"date":"2024-10-25","current":-9.89239,"twenty":-22.67436,"median":-11.242131,"eighty":-10.104324,"marketCap":7131067681},{"date":"2024-10-31","current":-9.742538,"twenty":-22.644989,"median":-11.044111,"eighty":-9.940343,"marketCap":7023044583},{"date":"2024-11-08","current":-12.029604,"twenty":-22.343937,"median":-10.984171,"eighty":-9.885968,"marketCap":8941340337},{"date":"2024-11-15","current":-11.995712,"twenty":-20.467134,"median":-11.242131,"eighty":-9.940343,"marketCap":8916149028},{"date":"2024-11-22","current":-11.116634,"twenty":-17.156812,"median":-11.333112,"eighty":-9.959181,"marketCap":8262749443},{"date":"2024-11-29","current":-13.258196,"twenty":-15.952624,"median":-11.432255,"eighty":-9.973738,"marketCap":9854525298},{"date":"2024-12-06","current":-11.260676,"twenty":-15.430514,"median":-11.47731,"eighty":-10.055515,"marketCap":8369812508},{"date":"2024-12-13","current":-8.894578,"twenty":-14.914582,"median":-11.360942,"eighty":-9.928355,"marketCap":6611144229},{"date":"2024-12-20","current":-6.996616,"twenty":-14.515749,"median":-11.205913,"eighty":-9.802907,"marketCap":5200430909},{"date":"2024-12-27","current":-7.475343,"twenty":-14.417732,"median":-11.110343,"eighty":-9.696726,"marketCap":5556258153},{"date":"2025-01-03","current":-7.255044,"twenty":-14.310948,"median":-11.04193,"eighty":-9.447445,"marketCap":5392514642},{"date":"2025-01-10","current":-7.941361,"twenty":-13.904149,"median":-10.968115,"eighty":-9.277996,"marketCap":5902638655},{"date":"2025-01-17","current":-7.360957,"twenty":-13.814237,"median":-10.857866,"eighty":-8.901726,"marketCap":5471237484},{"date":"2025-01-24","current":-11.616544,"twenty":-13.589703,"median":-10.821474,"eighty":-8.900296,"marketCap":8634321255},{"date":"2025-01-31","current":-12.114335,"twenty":-13.372582,"median":-10.83967,"eighty":-9.084572,"marketCap":9004318610},{"date":"2025-02-07","current":-13.766579,"twenty":-13.580172,"median":-10.892118,"eighty":-9.145072,"marketCap":10232394938},{"date":"2025-02-14","current":-17.740436,"twenty":-14.414343,"median":-10.977749,"eighty":-9.176796,"marketCap":13186075951},{"date":"2025-02-21","current":-16.251299,"twenty":-14.626169,"median":-11.042495,"eighty":-9.240319,"marketCap":12079232799},{"date":"2025-02-28","current":-13.492832,"twenty":-14.626169,"median":-11.116634,"eighty":-9.28821,"marketCap":9523362310},{"date":"2025-03-07","current":-11.921515,"twenty":-14.53127,"median":-11.296894,"eighty":-9.306641,"marketCap":8414312522},{"date":"2025-03-14","current":-10.287979,"twenty":-14.446116,"median":-11.151149,"eighty":-9.381512,"marketCap":7261348495},{"date":"2025-03-21","current":-11.72144,"twenty":-14.421968,"median":-11.296894,"eighty":-9.48981,"marketCap":8273098108},{"date":"2025-03-28","current":-12.680334,"twenty":-14.416037,"median":-11.432255,"eighty":-9.599308,"marketCap":8949894019},{"date":"2025-04-04","current":-11.318823,"twenty":-14.402423,"median":-11.47731,"eighty":-9.665899,"marketCap":7988927284},{"date":"2025-04-11","current":-9.87731,"twenty":-14.338727,"median":-11.360942,"eighty":-9.665899,"marketCap":6971494050},{"date":"2025-04-17","current":-10.017048,"twenty":-14.29676,"median":-11.318823,"eighty":-9.696726,"marketCap":7070122782},{"date":"2025-04-25","current":-13.115812,"twenty":-14.136074,"median":-11.289749,"eighty":-9.724555,"marketCap":9257258170},{"date":"2025-04-30","current":-13.309485,"twenty":-13.904149,"median":-11.333112,"eighty":-9.729693,"marketCap":9393954132}],"updateTime":1746105162422}}}